HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice.

AbstractBACKGROUND/AIMS:
Prostacyclin (PGI(2)) is a potent mediator in the inflammatory and coagulation processes. The aim of this study was to test whether beraprost sodium, a PGI(2) analogue, could prevent experimental hepatic injury induced by concanavalin A (Con A), which is a model of fulminant hepatic failure.
METHODS:
Beraprost (100 microg/kg) was administered intraperitoneally simultaneously with Con A (40 mg/kg) in C57B6J mice. Blood circulation in the liver was determined by laser-Doppler flowmetry. Plasma levels of alanine aminotransferase (ALT), tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and interleukin (IL)-6 were determined. Levels of TNF-alpha and IFN-gamma in culture supernatant of splenocytes were also determined.
RESULTS:
Beraprost administration reduced the incidence of death following hepatic failure (76.5% vs. 29.4%, P<0.05). Plasma levels of ALT were significantly lower in the beraprost-treated group than in the control group, and in the former, there was concomitant suppression of the histological features of injury. Beraprost significantly increased hepatic blood flow volume in Con A-treated mice. Plasma levels of TNF-alpha and IFN-gamma were significantly reduced at 6 and 12 h after Con A injection, respectively, but the levels of IL-6 were increased at 6 h. In vitro, beraprost also suppressed Con A-induced TNF-alpha production in splenocytes, while it stimulated IFN-gamma production.
CONCLUSION:
These findings imply that beraprost suppresses Con A-induced liver injury. These data also suggest that beraprost, which is clinically effective in treating pulmonary hypertension, may have therapeutic potential for preventing hepatic injury.
AuthorsSatoshi Ohta, Makoto Nakamuta, Marie Fukushima, Motoyuki Kohjima, Kazuhiro Kotoh, Munechika Enjoji, Hajime Nawata
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 25 Issue 5 Pg. 1061-8 (Oct 2005) ISSN: 1478-3223 [Print] United States
PMID16162167 (Publication Type: Journal Article)
Chemical References
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • Nitric Oxide
  • beraprost
  • Interferon-gamma
  • Epoprostenol
Topics
  • Animals
  • Concanavalin A (toxicity)
  • Epoprostenol (analogs & derivatives, therapeutic use)
  • Interferon-gamma (biosynthesis, blood)
  • Interleukin-6 (blood)
  • Liver Circulation (drug effects)
  • Liver Failure, Acute (drug therapy)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide (biosynthesis)
  • Spleen (cytology, metabolism)
  • Tumor Necrosis Factor-alpha (analysis, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: